ArticleBreast cancer research : BCR2025

Low dose DNA methyltransferase inhibitors potentiate PARP inhibitors in homologous recombination repair deficient tumors.

Romain Pacaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.